With the aim of creating a conducive environment that fosters research and new drug development in India, the government has amended some critical clauses and framed new guidelines that are aligned to global regulations. In an interview with BioSpectrum Asia Magazine, Suneela Thatte, president, Indian Society for Clinical Research said...